Published in Hepatitis Weekly, August 30th, 1999
Screening and confirmatory low cost reagent tests have been developed for detection of anti-hepatitis C virus (HCV). Assays are based on the use of specific synthetic peptides from several structural and non-structural viral proteins.
In this study, A. Palacios and colleagues compared the efficacy of the screening anti-HCV EIA-Spep assay with both Abbott EIA 2.0 (Abbott Laboratories, North Chicago, Illinois) and Ortho EIA 2.0 (Ortho Diagnostic Systems, Raritan, New Jersey) anti-HCV detection. They also compared the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.